Evexia Lifecare Ltd. (BSE: 524444), engaged in the trading of chemicals, manufacturing of intermediates, agricultural produce and various other products of consumer goods, has announced that the company has approved the issuance of up to 24 Crore Convertible Warrants, of the company, at a price of Rs. 3.60/- per Warrant aggregating to up to Rs.86.40 Cr by way of preferential issue, subject to necessary approval of the members of the Company and other regulatory authorities, as maybe applicable.
Recently, the company announced that its members approved the issue of the foreign currency convertible bonds in the Annual General Meeting held on July 9, 2022. The board has considered and approved conversion of 25 bonds into equity shares as per the terms and conditions of the issue of FCCB. Recently, the Board of Directors at its meeting held on June 17, 2024 had also considered and approved conversion of 75 bonds into equity shares as per the terms and conditions of the issue of FCCB.
Earlier, Evexia Lifecare Ltd. Announced that it had incorporated a Subsidiary Company namely “EVEXIA LIFECARE AFRICA LIMITED (CIN: 14497377)”which is registered with the Registrar of Companies for England and Wales. The Registrar of Companies for England and Wales has issued a Certificate of Incorporation for the same. Evexia Lifecare Formed the New Subsidiary to Set Up Pathology Labs in Africa